Jonathan Knight, Novartis goes public with DNA data in bid to tackle diabetes, Nature, October 28, 2004 (accessible only to subscribers). Excerpt: "It is rare for a private company to pay for a large public database. 'To make it public is a good move for science, but it is unusual,' says Sheldon Krimsky, a science-policy researcher at Tufts University in Medford,Massachusetts. Companies usually require a much more direct commercial benefit from such a partnership, he says. The project is likely to generate far more data than the company can use, says Tom Hughes, head of diabetes research at Novartis Institutes. Releasing it will help the field as a whole,which in turn could lead to other commercial opportunities, he suggests. 'We don't have to hold it all to ourselves to advance as a company.' "
Posted by
Peter Suber at 10/29/2004 09:43:00 AM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
